HLA-B55 antigen

Also Known As:

HLA B55; HLA Bw55; HLA Bw55 antigen; HLA-B55; HLA-Bw55

Networked: 10 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B55 antigen: 10

Experts

1.	Torigoe, Toshihiko: 3 articles (04/2019 - 06/2009)
2.	Tsukahara, Tomohide: 3 articles (04/2019 - 06/2009)
3.	Toji, Shingo: 2 articles (04/2019 - 08/2014)
4.	Watanabe, Kazue: 2 articles (04/2019 - 08/2014)
5.	Sato, Noriyuki: 2 articles (08/2014 - 06/2009)
6.	Wada, Takuro: 2 articles (08/2014 - 06/2009)
7.	Yamashita, Toshihiko: 2 articles (08/2014 - 06/2009)
8.	Li, Dongliang: 1 article (04/2019)
9.	Anholts, J D H: 1 article (08/2017)
10.	Claas, F H J: 1 article (08/2017)

Related Diseases

1.	Osteosarcoma (Osteogenic Sarcoma) 06/12/2009 - "To develop peptide-based immunotherapy for osteosarcoma, we previously identified papillomavirus binding factor (PBF) as a CTL-defined osteosarcoma antigen in the context of HLA-B55. " 04/01/2019 - "To develop peptide-based immunotherapy for osteosarcoma, we previously identified CTL epitopes derived from papillomavirus binding factor (PBF) in the context of human leukocyte antigen (HLA)-A2, HLA-A24 and HLA-B55. " 08/08/2014 - "To develop peptide-based immunotherapy, we previously identified autologous cytotoxic T lymphocyte-defined osteosarcoma antigen papillomavirus binding factor (PBF) in the context of HLA-B55 and the cytotoxic T lymphocyte epitope (PBF A2.2) presented by HLA-A2. "
2.	Chronic Hepatitis C 06/01/1997 - "These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C."
3.	Viremia 04/01/2017 - "Cadaveric transplantation and matching human leukocyte antigen (HLA) A24 and HLA B55 subgroups were found to be independent risk factors for BK viremia [odds ratio (OR), 3.65; 95% confidence interval (CI), 1.42-9.39; P < .001; OR, 4.94; 95% CI, 1.84-13.2; P < .001 and OR, 14.03; 95% CI, 1.07-183.5; P = .04, respectively]. "
4.	Neoplasms (Cancer) 03/29/1994 - "Results presented here identify T-cell clonotypes that recognize epitopes on highly prevalent, shared melanoma tumor-associated antigens presented in the context of HLA-B55, HLA-A1, and HLA-A2. "
5.	Melanoma (Melanoma, Malignant) 03/29/1994 - "Results presented here identify T-cell clonotypes that recognize epitopes on highly prevalent, shared melanoma tumor-associated antigens presented in the context of HLA-B55, HLA-A1, and HLA-A2. "

Related Drugs and Biologics

1.	Antigens
2.	Peptides (Polypeptides)
3.	HLA Antigens (Human Leukocyte Antigens)
4.	Epitopes
5.	HLA-A24 Antigen
6.	HLA-A2 Antigen (HLA A2 Antigen)
7.	HLA-B51 Antigen
8.	HLA-B38 Antigen
9.	HLA-B13 Antigen
10.	HLA-A11 Antigen

Related Therapies and Procedures

1.	Immunotherapy
2.	Transplantation